Benzinga - Hong Kong stocks soared on Monday morning, with the benchmark Hang Seng index rising over 3%, as China relieved some of its COVID-19 restrictions, easing testing rules in some cities.
Alibaba (NYSE:BABA) Group Holding Ltd. (NYSE: BABA) | 5.01% |
JD.com Inc (NASDAQ: JD) | 7.18% |
Baidu Inc (NASDAQ: NASDAQ:BIDU) | 7.35% |
Tencent Holdings (HK:0700) Ltd. (OTC: TCEHY) | 5.61% |
Meituan (OTC: MPNGF) | 3.1% |
Nio Inc (NYSE: NIO) | 12.44% |
XPeng Inc (NYSE: XPEV) | 19.62% |
Li Auto Inc (NASDAQ: LI) | 10.05% |
Also Read: How To Invest In Startups
Macro News: More Chinese cities including Urumqi eased coronavirus restrictions on Sunday as China tries to make its zero-COVID policy more targeted, reported Reuters.
China’s offshore yuan rose past the key level of 7-per-dollar level for the first time since September, as authorities start focussing on reopening the economy, reported Bloomberg.
Company News: China Evergrande Group’s (OTC: EGRNF) electric vehicle unit has suspended mass production of its only model owing to a lack of new orders, reported Reuters citing sources.
Volkswagen (ETR:VOWG_p) Group (OTC: VWAGY) is facing complaints in China owing to on-board system failures in ID series EVs, reported CnEVPost.
Top Gainers and Losers: Alibaba Health Information Technology Limited and Xiaomi Corporation are the top gainers among Hang Seng constituents, having risen over 17% and 7%, respectively. Lenovo Group Limited and China Resources Land Limited were the top losers, having shed 1.11% and 0.6%, respectively.
Global News: U.S. futures traded in the red on Friday morning Asia session. The Dow Jones futures declined 0.05% while the Nasdaq futures lost 0.13%. The S&P 500 futures were trading lower by 0.12%.
Elsewhere in Asia-Pacific, Australia’s ASX 200 was up 0.61%. Japan’s Nikkei 225 traded 0.02% higher while China’s Shanghai Composite index rose 1.48%. South Korea’s Kospi fell 0.45%.
Read Next: 'Big Short' Investor Michael Burry Puts Out Cryptic Hong Kong Tweet As Alibaba, Nio Soar In Strong Hang Seng Open
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.